Skip to main content

Closed

XGN: Exagen Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+5.9% / yr

Operating margin-20.6%

ROIC-33.3%

Financially safe

Stretched

Debt / equity1.76×

Interest coverage-2.8×

Current ratio3.47×

Exagen Inc.

XGNNASDAQ Global Market·USD·Closed

Exagen Inc.

XGNNASDAQ·USD·Closed

$4.53

−3.00%

$4.53

−$0.14 (3.00%)

52W Range

20thpctl

Volume

0.26×avg

Mkt Cap

109.44MUSD

P/E

-5.0TTM

Div Yield

–ann

52W Range

20thpctl

Volume

0.26×avg

Market Cap

109.44MUSD

P/E Ratio

-5.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings